Endothelial Dysfunction and Cardiovascular Remodeling in Pathophyisiology of Prehypertension
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Hypertension,Essential
- Sponsor
- Josip Juraj Strossmayer University of Osijek
- Enrollment
- 90
- Locations
- 1
- Primary Endpoint
- Aortic stiffness
- Status
- Not yet recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
In the frame of this proposal investigators will test the hypothesis that high normal blood pressure (prehypertension; PreHT) induces systemic endothelial dysfunction and endothelial activation in both micro- and macrocirculation, reduces re-endothelialization potential of human endothelial progenitor cells (EPCs) and increases the level of endothelial extracellular vesicles (EVs), which are accompanied by increased oxidative stress level. Furthermore, initial vascular and left ventricle (LV) remodeling contributes to changes in systemic hemodynamics and may be influenced by altered regulatory role of renin-angiotensin system (RAS) and autonomic nervous system (ANS) in PreHT but otherwise healthy individuals. To distinguish high normal blood pressure effect from those considered normal or high, study will be performed in three groups of individuals: prehypertensive (BP 130-139/85-89 mmHg), hypertensive (stage I, BP 140-150/90-100 mmHg), and controls (BP less than or equal to 129/85 mmHg). Altogether, the impairment of normal vascular relaxation mechanisms, endothelial activation as well as vascular and LV remodeling could play crucial role in increased cardiovascular risk and CVDs incidence in PreHT individuals. Moreover, the prognostic significance of assessing endotehlial dysfunction in hypertension (as well as in PreHT) is yet to be established.
Investigators
Ines Drenjancevic
Vice Dean for Science Faculty of Medicine Osijek
Josip Juraj Strossmayer University of Osijek
Eligibility Criteria
Inclusion Criteria
- •adults of both sexes with normotensive, prehypertensive and grade I hypertension blood pressure values
Exclusion Criteria
- •cardiovascular diseases, but grade I hypertension (BP 140-150/90-100 mmHg)
- •kidney disease
- •cerebrovascular diseases
- •peripheral artery disease
- •taking oral contraceptives or any drugs that could affect the endothelium
Outcomes
Primary Outcomes
Aortic stiffness
Time Frame: Day 1
Measurement of pulse wave velocity (PWV) using impedance cardiography.
Left ventricle global longitudinal strain
Time Frame: Day 1
Global longitudinal strain (GLS) of left ventricle obtained by two-dimensional speckle tracking echocardiography.
Systemic microvascular function
Time Frame: Day 1
Skin microvascular reactivity assessed by Laser Doppler flowmetry (post-occlusive reactive hyperemia, iontophoresis of acetylcholine and sodium nitroprusside, local thermal hyperemia) - measured in perfusion units (PU)
Systemic macrovascular function
Time Frame: Day 1
Vascular ultrasound measurement of brachial artery flow mediated dilation (FMD)
Secondary Outcomes
- Oxidative stress - 8-iso-prostaglandin F2α (8-iso-PGF2α)(Day 1)
- Endothelial extracellular vesicles (eEVs)(Day 1)
- Systemic peripheral vascular resistance(Day 1)
- Matrix metalloproteinase 9(Day 1)
- Autonomic nervous system (ANS) activity(Day 1)
- Activity of renin-angiotensin system (RAS)(Day 1)
- Endothelial progenitor cells (EPCs)(Day 1)